Daley G Q, Van Etten R A, Baltimore D
Whitehead Institute for Biomedical Research, Cambridge, MA 02142.
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11335-8. doi: 10.1073/pnas.88.24.11335.
The P210bcr/abl protein is produced in cells from patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Retroviral transfer of the gene encoding P210bcr/abl into murine bone marrow induces a granulocytic leukemia that models the chronic phase of human CML. We have transferred the leukemic clone to syngeneic animals, albeit with surprising inefficiency, and have observed CML and clonally related acute leukemias of lymphoid or myeloid phenotype in some transplant recipients. These data show that murine CML can result from retroviral transfer of the bcr/abl gene into pluripotent hematopoietic stem cells, that infected clones repopulate poorly after adoptive transfer, and that these clones can give rise to acute leukemia, reflecting evolution to a phase resembling blast crisis in the human disease.
P210bcr/abl蛋白在费城染色体阳性慢性粒细胞白血病(CML)患者的细胞中产生。将编码P210bcr/abl的基因通过逆转录病毒转移到小鼠骨髓中可诱发粒细胞白血病,该白血病可模拟人类CML的慢性期。我们已将白血病克隆转移到同基因动物中,尽管效率令人惊讶地低,并且在一些移植受体中观察到了CML以及具有淋巴样或髓样表型的克隆相关急性白血病。这些数据表明,小鼠CML可能源于bcr/abl基因通过逆转录病毒转移到多能造血干细胞中,受感染的克隆在过继转移后再增殖能力差,并且这些克隆可引发急性白血病,这反映了其向类似于人类疾病急变期的阶段演变。